CPA
ABBV icon

Cardiff Park Advisors’s AbbVie ABBV Stock Holding History

Cardiff Park Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$869K Sell
3,996
-17
-0.4% -$3.77K 0.07% 131
2025
Q4 		$917K Sell
4,013
-327
-8% -$74.5K 0.08% 126
2025
Q3 		$1M Buy
4,340
+18
+0.4% +$3.67K 0.08% 127
2025
Q2 		$802K Buy
4,322
+1
+0% +$186 0.07% 131
2025
Q1 		$905K Buy
4,321
+11
+0.3% +$2.14K 0.09% 115
2024
Q4 		$766K Sell
4,310
-438
-9% -$80.5K 0.07% 125
2024
Q3 		$938K Buy
4,748
+1
+0% +$187 0.08% 107
2024
Q2 		$814K Buy
4,747
+101
+2% +$16.7K 0.08% 113
2024
Q1 		$846K Hold
4,646
– – 0.08% 115
2023
Q4 		$720K Hold
4,646
– – 0.08% 120
2023
Q3 		$693K Hold
4,646
– – 0.09% 111
2023
Q2 		$626K Sell
4,646
-1,500
-24% -$220K 0.08% 125
2023
Q1 		$980K Buy
6,146
+139
+2% +$21.3K 0.13% 89
2022
Q4 		$971K Sell
6,007
-834
-12% -$128K 0.14% 93
2022
Q3 		$918K Sell
6,841
-118
-2% -$16.9K 0.14% 89
2022
Q2 		$1.07M Buy
6,959
+83
+1% +$12.7K 0.16% 73
2022
Q1 		$1.11M Sell
6,876
-77
-1% -$11.2K 0.16% 70
2021
Q4 		$941K Buy
+6,953
New +$821K 0.12% 78

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cardiff Park Advisors's ABBV Position: Q1 2026 in Review

Cardiff Park Advisors reduced its AbbVie (ABBV) stake by 0.42% in Q1 2026, selling an estimated $3.77K and leaving 3,996 shares worth $869K. The position accounts for 0.07% of the portfolio, ranked #131.

Cardiff Park Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.11M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cardiff Park Advisors held 3,996 shares of AbbVie worth $869K as of Q1 2026.
  • Cardiff Park Advisors sold 17 AbbVie shares in Q1 2026, an estimated $3.77K.
  • AbbVie made up 0.07% of Cardiff Park Advisors's portfolio in Q1 2026, its #131 holding.
  • Cardiff Park Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Cardiff Park Advisors's AbbVie position peaked at $1.11M in Q1 2022.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.